Adoptive cell therapy (ACT) is an antitumor therapy in which autologous immune cells are activated in vitro by interleukin-2 (IL-2) as well as other cytokines, amplified to a certain number, and then injected back into the body of cancer patients where they can kill tumor cells in vivo [156, 157]. This evidence concerns the gene IL2 and neoplasm.